デフォルト表紙
市場調査レポート
商品コード
1387373

禁煙・ニコチン依存症対策製品市場レポート:2030年までの動向、予測、競合分析

Smoking Cessation and Nicotine De-Addiction Products Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意: DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

禁煙・ニコチン依存症対策製品市場レポート:2030年までの動向、予測、競合分析
出版日: 2023年11月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

禁煙・ニコチン依存症対策製品の動向と予測

世界の禁煙・ニコチン依存症対策製品市場は、2024年から2030年にかけてCAGR 16.0%で成長すると予測されます。この市場の主な促進要因は、喫煙に伴う健康リスクと禁煙のメリットに対する意識の高まり、タバコの箱のグラフィック警告や公共の場での喫煙禁止などの規制強化です。世界の禁煙・ニコチン依存症対策製品市場は、病院薬局、オンラインプロバイダー、ドラッグストア、小売薬局市場にビジネスチャンスがあり、将来性が期待されます。

禁煙・ニコチン依存症対策製品市場の洞察

Lucintelの予測では、ニコチン代替療法製品の需要拡大により、ガムが引き続き最大セグメントとなります。

この市場の中では、急速なデジタル化、購入の容易さ、製品の迅速な配達により、オンラインプロバイダーが最も高い成長を示すと予想されます。

北米は、政府のイニシアチブの増加、整備されたヘルスケアインフラの存在、同地域における電子タバコの高い普及率により、予測期間中最大の地域であり続けると思われます。

本レポートでは、以下の11の主要な質問に回答している:

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か?
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は?
  • Q.3.今後成長が加速すると思われる地域とその理由は?
  • Q.4.市場力学に影響を与える主な要因は何か?市場における主な課題とビジネスリスクは?
  • Q.5.この市場におけるビジネスリスクと競合の脅威は?
  • Q.6.この市場における新たな動向とその理由は?
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか?
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は?
  • Q.9.この市場における主要企業は?主要企業は事業成長のためにどのような戦略的取り組みを進めているのか?
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか?
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか?

目次

第1章 エグゼクティブサマリー

第2章 世界の禁煙・ニコチン依存症対策製品市場:市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向(2018~2023年)と予測(2024~2030年)
  • 世界の禁煙・ニコチン依存症対策製品市場の動向(2018~2023年)および予測(2024~2030年)
  • 形態別の世界の禁煙・ニコチン依存症対策製品市場
    • ガム
    • 吸入器
    • タブレット
    • その他
  • 製品別の世界の禁煙・ニコチン依存症対策製品市場
    • ニコチン代替療法製品
    • 薬物療法
    • 電子タバコ
  • 流通チャネル別の世界の禁煙・ニコチン依存症対策製品市場
    • 病院薬局
    • オンラインプロバイダー
    • ドラッグストア・小売薬局

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の禁煙・ニコチン依存症対策製品市場
  • 北米の禁煙・ニコチン依存症対策製品市場
  • 欧州の禁煙・ニコチン依存症対策製品市場
  • アジア太平洋の禁煙・ニコチン依存症対策製品市場
  • その他地域の禁煙・ニコチン依存症対策製品市場

第5章 競合分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 形態別の世界の禁煙・ニコチン依存症対策製品市場の成長機会
    • 製品別の世界の禁煙・ニコチン依存症対策製品市場の成長機会
    • 流通チャネル別の世界の禁煙・ニコチン依存症対策製品市場の成長機会
    • 地域別の世界の禁煙・ニコチン依存症対策製品市場の成長機会
  • 世界の禁煙・ニコチン依存症対策製品市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の禁煙・ニコチン依存症対策製品市場の能力拡大
    • 世界の禁煙・ニコチン依存症対策製品市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Pfizer
  • Imperial Brands
  • Njoy Company
  • GlaxoSmithKline
  • British American Tobacco
  • Perrigo Company
  • Johnson and Johnson
  • Rusan Pharma
  • Dr. Reddy's Laboratories
  • 22nd Century
目次

Smoking Cessation and Nicotine De-Addiction Products Trends and Forecast

The future of the global smoking cessation and nicotine de-addiction products market looks promising with opportunities in the hospital pharmacies, online provider, drug stores and retail pharmacies markets. The global smoking cessation and nicotine de-addiction products market is expected to grow with a CAGR of 16.0% from 2024 to 2030. The major drivers for this market are increased awareness of the health risks associated with smoking and the benefits of quitting and increasing stringent regulations like graphic warnings on cigarette packs and smoking bans in public places.

A more than 150-page report is developed to help in your business decisions.

Smoking Cessation and Nicotine De-Addiction Products by Segment

The study includes a forecast for the global smoking cessation and nicotine de-addiction products by form, product, distribution channel, and region.

Smoking Cessation and Nicotine De-Addiction Products Market by Form [Shipment Analysis by Value from 2018 to 2030]:

  • Gum
  • Inhaler
  • Tablet
  • Others

Smoking Cessation and Nicotine De-Addiction Products Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Nicotine Replacement Therapy Products
  • Drug Therapy
  • E-Cigarettes

Smoking Cessation and Nicotine De-Addiction Products Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital Pharmacies
  • Online Provider
  • Drug Stores and Retail Pharmacies

Smoking Cessation and Nicotine De-Addiction Products Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Smoking Cessation and Nicotine De-Addiction Products Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies smoking cessation and nicotine de-addiction products companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the smoking cessation and nicotine de-addiction products companies profiled in this report include-

  • Pfizer
  • Imperial Brands
  • Njoy Company
  • Glaxosmithkline
  • British American Tobacco
  • Perrigo Company
  • Johnson And Johnson
  • Rusan Pharma
  • Dr. Reddy'S Laboratories
  • 22nd Century

Smoking Cessation and Nicotine De-Addiction Products Market Insights

Lucintel forecasts that gum will remain the largest segment due to growing demand for the nicotine replacement therapy products.

Within this market, online provider is expected to witness highest growth due to rapid digitalization, ease of purchase, and quicker delivery of products.

North America will remain the largest region over the forecast period due to increasing government initiatives, presence of well-developed healthcare infrastructure, and high adoption of e-cigarettes in the region.

Features of the Global Smoking Cessation and Nicotine De-Addiction Products Market

Market Size Estimates: Smoking cessation and nicotine de-addiction products market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Smoking cessation and nicotine de-addiction products market size by form, product, distribution channel, and region in terms of value ($B).

Regional Analysis: Smoking cessation and nicotine de-addiction products market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different forms, products, distribution channels, and regions for the smoking cessation and nicotine de-addiction products market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the smoking cessation and nicotine de-addiction products market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for smoking cessation and nicotine de-addiction products market?

Answer: The global smoking cessation and nicotine de-addiction products market is expected to grow with a CAGR of 16.0% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the smoking cessation and nicotine de-addiction products market?

Answer: The major drivers for this market are increased awareness of the health risks associated with smoking and the benefits of quitting and increasing stringent regulations like graphic warnings on cigarette packs and smoking bans in public places.

Q3. What are the major segments for smoking cessation and nicotine de-addiction products market?

Answer: The future of the smoking cessation and nicotine de-addiction products market looks promising with opportunities in the hospital pharmacies, online provider, drug stores and retail pharmacies markets.

Q4. Who are the key smoking cessation and nicotine de-addiction products market companies?

Answer: Some of the key smoking cessation and nicotine de-addiction products companies are as follows:

  • Pfizer
  • Imperial Brands
  • Njoy Company
  • Glaxosmithkline
  • British American Tobacco
  • Perrigo Company
  • Johnson And Johnson
  • Rusan Pharma
  • Dr. Reddy'S Laboratories
  • 22nd Century

Q5. Which smoking cessation and nicotine de-addiction products market segment will be the largest in future?

Answer: Lucintel forecasts that gum will remain the largest segment due to growing demand for the nicotine replacement therapy products.

Q6. In smoking cessation and nicotine de-addiction products market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing government initiatives, presence of well-developed healthcare infrastructure, and high adoption of e-cigarettes in the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the smoking cessation and nicotine de-addiction products market by form (gum, inhaler, tablet, and others), product (nicotine replacement therapy products, drug therapy, and e-cigarettes), distribution channel (hospital pharmacies, online provider, and drug stores and retail pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Smoking Cessation and Nicotine De-Addiction Products Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Smoking Cessation and Nicotine De-Addiction Products Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Smoking Cessation and Nicotine De-Addiction Products Market by Form
    • 3.3.1: Gum
    • 3.3.2: Inhaler
    • 3.3.3: Tablet
    • 3.3.4: Others
  • 3.4: Global Smoking Cessation and Nicotine De-Addiction Products Market by Product
    • 3.4.1: Nicotine Replacement Therapy Products
    • 3.4.2: Drug Therapy
    • 3.4.3: E-cigarettes
  • 3.5: Global Smoking Cessation and Nicotine De-Addiction Products Market by Distribution Channel
    • 3.5.1: Hospital Pharmacies
    • 3.5.2: Online Provider
    • 3.5.3: Drug stores and Retail Pharmacies

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Smoking Cessation and Nicotine De-Addiction Products Market by Region
  • 4.2: North American Smoking Cessation and Nicotine De-Addiction Products Market
    • 4.2.2: North American Smoking Cessation and Nicotine De-Addiction Products Market by Distribution Channel: Hospital Pharmacies, Online Provider, and Drug stores and Retail Pharmacies
  • 4.3: European Smoking Cessation and Nicotine De-Addiction Products Market
    • 4.3.1: European Smoking Cessation and Nicotine De-Addiction Products Market by Form: Gum, Inhaler, Tablet, and Others
    • 4.3.2: European Smoking Cessation and Nicotine De-Addiction Products Market by Distribution Channel: Hospital Pharmacies, Online Provider, and Drug stores and Retail Pharmacies
  • 4.4: APAC Smoking Cessation and Nicotine De-Addiction Products Market
    • 4.4.1: APAC Smoking Cessation and Nicotine De-Addiction Products Market by Form: Gum, Inhaler, Tablet, and Others
    • 4.4.2: APAC Smoking Cessation and Nicotine De-Addiction Products Market by Distribution Channel: Hospital Pharmacies, Online Provider, and Drug stores and Retail Pharmacies
  • 4.5: ROW Smoking Cessation and Nicotine De-Addiction Products Market
    • 4.5.1: ROW Smoking Cessation and Nicotine De-Addiction Products Market by Form: Gum, Inhaler, Tablet, and Others
    • 4.5.2: ROW Smoking Cessation and Nicotine De-Addiction Products Market by Distribution Channel: Hospital Pharmacies, Online Provider, and Drug stores and Retail Pharmacies

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Smoking Cessation and Nicotine De-Addiction Products Market by Form
    • 6.1.2: Growth Opportunities for the Global Smoking Cessation and Nicotine De-Addiction Products Market by Product
    • 6.1.3: Growth Opportunities for the Global Smoking Cessation and Nicotine De-Addiction Products Market by Distribution Channel
    • 6.1.4: Growth Opportunities for the Global Smoking Cessation and Nicotine De-Addiction Products Market by Region
  • 6.2: Emerging Trends in the Global Smoking Cessation and Nicotine De-Addiction Products Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Smoking Cessation and Nicotine De-Addiction Products Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Smoking Cessation and Nicotine De-Addiction Products Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Pfizer
  • 7.2: Imperial Brands
  • 7.3: Njoy Company
  • 7.4: GlaxoSmithKline
  • 7.5: British American Tobacco
  • 7.6: Perrigo Company
  • 7.7: Johnson and Johnson
  • 7.8: Rusan Pharma
  • 7.9: Dr. Reddy's Laboratories
  • 7.10: 22nd Century